These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Dual mechanism of brain injury and novel treatment strategy in maple syrup urine disease. Zinnanti WJ; Lazovic J; Griffin K; Skvorak KJ; Paul HS; Homanics GE; Bewley MC; Cheng KC; Lanoue KF; Flanagan JM Brain; 2009 Apr; 132(Pt 4):903-18. PubMed ID: 19293241 [TBL] [Abstract][Full Text] [Related]
9. Plasma amino acid and urine organic acid profiles of Filipino patients with maple syrup urine disease (MSUD) and correlation with their neurologic features. Chiong MA; Tan MA; Cordero CP; Fodra EG; Manliguis JS; Lopez CP; Dalmacio LM Mol Genet Metab Rep; 2016 Dec; 9():46-53. PubMed ID: 27761412 [TBL] [Abstract][Full Text] [Related]
10. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine. Riazi R; Rafii M; Clarke JT; Wykes LJ; Ball RO; Pencharz PB Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E142-9. PubMed ID: 14970005 [TBL] [Abstract][Full Text] [Related]
11. Imaging in classic form of maple syrup urine disease: a rare metabolic central nervous system. Jain A; Jagdeesh K; Mane R; Singla S J Clin Neonatol; 2013 Apr; 2(2):98-100. PubMed ID: 24049754 [TBL] [Abstract][Full Text] [Related]
12. Brain Branched-Chain Amino Acids in Maple Syrup Urine Disease: Implications for Neurological Disorders. Xu J; Jakher Y; Ahrens-Nicklas RC Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33050626 [TBL] [Abstract][Full Text] [Related]
13. Lipid changes in the metabolome of a single case study with maple syrup urine disease (MSUD) after five days of improved diet adherence of controlled branched-chain amino acids (BCAA). Douglas TD; Newby LK; Eckstrand J; Wixted D; Singh RH Mol Genet Metab Rep; 2020 Dec; 25():100651. PubMed ID: 33088714 [TBL] [Abstract][Full Text] [Related]
14. Domino liver transplantation in maple syrup urine disease. Khanna A; Hart M; Nyhan WL; Hassanein T; Panyard-Davis J; Barshop BA Liver Transpl; 2006 May; 12(5):876-82. PubMed ID: 16628687 [TBL] [Abstract][Full Text] [Related]
15. Acute Metabolic Crises in Maple Syrup Urine Disease After Liver Transplantation from a Related Heterozygous Living Donor. Al-Shamsi A; Baker A; Dhawan A; Hertecant J JIMD Rep; 2016; 30():59-62. PubMed ID: 27117295 [TBL] [Abstract][Full Text] [Related]
16. Production and characterization of murine models of classic and intermediate maple syrup urine disease. Homanics GE; Skvorak K; Ferguson C; Watkins S; Paul HS BMC Med Genet; 2006 Mar; 7():33. PubMed ID: 16579849 [TBL] [Abstract][Full Text] [Related]
18. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study. Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286 [TBL] [Abstract][Full Text] [Related]